| Net Cash Provided by (Used in) Operating Activities |
2.25M |
USD |
-5.55% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-3.69M |
USD |
-308% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
1.25M |
USD |
+84.1% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
7.75M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-182K |
USD |
-108% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
368M |
USD |
-2.55% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-1.18M |
USD |
-124% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
-101K |
USD |
|
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
23M |
USD |
+0.14% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
5.73M |
USD |
-3.62% |
Q4 2024 |
FY 2024 |